NCT05455112View on ClinicalTrials.gov

Safety and Efficacy of RUTI® With the Standard of Treatment for Tuberculosis

PHASE2RecruitingINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

October 29, 2022

Primary Completion Date

August 31, 2024

Study Completion Date

December 31, 2024

Conditions
Tuberculosis, Pulmonary
Interventions
BIOLOGICAL

RUTI® Vaccine

One subcutaneous injection of RUTI 25µg FCMtb

BIOLOGICAL

Placebo

One subcutaneous injection of saline

Trial Locations (2)

M5547

RECRUITING

Hospital José Nestor Lencinas, Godoy Cruz

T4001KKP

RECRUITING

Hospital de Clínicas Presidente Dr. Nicolás Avellaneda, San Miguel de Tucumán

Sponsors
All Listed Sponsors
lead

Archivel Farma S.L.

INDUSTRY

NCT05455112 - Safety and Efficacy of RUTI® With the Standard of Treatment for Tuberculosis | Biotech Hunter | Biotech Hunter